These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 30523734)

  • 21. Development of blood-based biomarker tests for early detection of colorectal neoplasia: Influence of blood collection timing and handling procedures.
    Lech Pedersen N; Mertz Petersen M; Ladd JJ; Lampe PD; Bresalier RS; Davis GJ; Demuth C; Jensen SØ; Andersen CL; Ferm L; Christensen IJ; Nielsen HJ
    Clin Chim Acta; 2020 Aug; 507():39-53. PubMed ID: 32272156
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cancer Antigens (CEA and CA 19-9) as Markers of Advanced Stage of Colorectal Carcinoma.
    Vukobrat-Bijedic Z; Husic-Selimovic A; Sofic A; Bijedic N; Bjelogrlic I; Gogov B; Mehmedovic A
    Med Arch; 2013 Dec; 67(6):397-401. PubMed ID: 25568506
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasma TIMP-1 in patients with colorectal adenomas: a prospective study.
    Holten-Andersen MN; Fenger C; Nielsen HJ; Rasmussen AS; Christensen IJ; Brünner N; Kronborg O
    Eur J Cancer; 2004 Sep; 40(14):2159-64. PubMed ID: 15341992
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An elevated preoperative serum carbohydrate antigen 19-9 level is a significant predictor for peritoneal dissemination and poor survival in colorectal cancer.
    Takakura Y; Ikeda S; Imaoka Y; Urushihara T; Itamoto T
    Colorectal Dis; 2015 May; 17(5):417-25. PubMed ID: 25512077
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum SYPL1 is a promising diagnostic biomarker for colorectal cancer.
    Liu L; He Q; Li Y; Zhang B; Sun X; Shan J; Pan B; Zhang T; Zhao Z; Song X; Guo Y
    Clin Chim Acta; 2020 Oct; 509():36-42. PubMed ID: 32502495
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased MACC1 levels in tissues and blood identify colon adenoma patients at high risk.
    Ashktorab H; Hermann P; Nouraie M; Shokrani B; Lee E; Haidary T; Brim H; Stein U
    J Transl Med; 2016 Jul; 14(1):215. PubMed ID: 27439755
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Attendance at surveillance endoscopy of patients with adenoma or colorectal cancer.
    Mulder SA; Van Leerdam ME; Ouwendijk RJ; Bac DJ; Giard RW; Kuipers EJ
    Scand J Gastroenterol; 2007 Jan; 42(1):66-71. PubMed ID: 17190765
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plasma matrix metalloproteinase 9 as an early surrogate biomarker of advanced colorectal neoplasia.
    Gimeno-García AZ; Triñanes J; Quintero E; Salido E; Nicolás-Pérez D; Adrián-de-Ganzo Z; Alarcón-Fernández O; Abrante B; Romero R; Carrillo M; Ramos L; Alonso I; Ortega J; Jiménez A
    Gastroenterol Hepatol; 2016; 39(7):433-41. PubMed ID: 26601990
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Proximal fluid proteome profiling of mouse colon tumors reveals biomarkers for early diagnosis of human colorectal cancer.
    Fijneman RJ; de Wit M; Pourghiasian M; Piersma SR; Pham TV; Warmoes MO; Lavaei M; Piso C; Smit F; Delis-van Diemen PM; van Turenhout ST; Terhaar sive Droste JS; Mulder CJ; Blankenstein MA; Robanus-Maandag EC; Smits R; Fodde R; van Hinsbergh VW; Meijer GA; Jimenez CR
    Clin Cancer Res; 2012 May; 18(9):2613-24. PubMed ID: 22351690
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Diagnostic and Prognostic Significance of Serum Neutrophil Gelatinase-Associated Lipocalin Levels in Patients with Colorectal Cancer.
    Ozemir IA; Aslan S; Eren T; Bayraktar B; Bilgic C; Isbilen B; Yalman H; Yigitbasi R; Alimoglu O;
    Chirurgia (Bucur); 2016; 111(5):414-421. PubMed ID: 27819647
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pretreatment serum levels of hematopoietic cytokines in patients with colorectal adenomas and cancer.
    Mroczko B; Szmitkowski M; Wereszczyńska-Siemiatkowska U; Okulczyk B; Kedra B
    Int J Colorectal Dis; 2007 Jan; 22(1):33-8. PubMed ID: 16520929
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fluorescence endoscopy using a fluorescein-labeled monoclonal antibody against carcinoembryonic antigen in patients with colorectal carcinoma and adenoma.
    Keller R; Winde G; Terpe HJ; Foerster EC; Domschke W
    Endoscopy; 2002 Oct; 34(10):801-7. PubMed ID: 12244502
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased incidence of colorectal adenomas in follow-up evaluation of patients with newly diagnosed hyperplastic polyps.
    Huang EH; Whelan RL; Gleason NR; Maeda JS; Terry MB; Lee SW; Neugut AI; Forde KA
    Surg Endosc; 2001 Jul; 15(7):646-8. PubMed ID: 11591960
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Postoperative CEA is a better prognostic marker than CA19-9, hCGβ or TATI after resection of colorectal liver metastases.
    Peltonen R; Österlund P; Lempinen M; Nordin A; Stenman UH; Isoniemi H
    Tumour Biol; 2018 Jan; 40(1):1010428317752944. PubMed ID: 29378497
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Soluble intercellular adhesion molecule-1 is a prognostic marker in colorectal carcinoma.
    Schellerer VS; Langheinrich MC; Zver V; Grützmann R; Stürzl M; Gefeller O; Naschberger E; Merkel S
    Int J Colorectal Dis; 2019 Feb; 34(2):309-317. PubMed ID: 30470940
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnostic value evaluation of trefoil factors family 3 for the early detection of colorectal cancer.
    Xie H; Guo JH; An WM; Tian ST; Yu HP; Yang XL; Wang HM; Guo Z
    World J Gastroenterol; 2017 Mar; 23(12):2159-2167. PubMed ID: 28405143
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MAPRE1 as a plasma biomarker for early-stage colorectal cancer and adenomas.
    Taguchi A; Rho JH; Yan Q; Zhang Y; Zhao Y; Xu H; Tripathi SC; Wang H; Brenner DE; Kucherlapati M; Kucherlapati R; Boutin AT; Wang YA; DePinho RA; Feng Z; Lampe PD; Hanash SM
    Cancer Prev Res (Phila); 2015 Nov; 8(11):1112-9. PubMed ID: 26342024
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The utility of tumor marker combination, including serum P53 antibody, in colorectal cancer treatment.
    Tokunaga R; Sakamoto Y; Nakagawa S; Yoshida N; Baba H
    Surg Today; 2017 May; 47(5):636-642. PubMed ID: 28062920
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of predictive markers for patients with advanced colorectal cancer.
    Byström P; Berglund Å; Nygren P; Wernroth L; Johansson B; Larsson A; Glimelius B
    Acta Oncol; 2012 Sep; 51(7):849-59. PubMed ID: 22974092
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The diagnostic value of serum carcino-embryonic antigen, alpha fetoprotein and carbohydrate antigen 19-9 for colorectal cancer.
    Wang YR; Yan JX; Wang LN
    J Cancer Res Ther; 2014 Dec; 10 Suppl():307-9. PubMed ID: 25693941
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.